上海医药：公司通过提升全价值链服务能级，打造细分领域的专业化平台

Core Viewpoint - The company has been enhancing its full value chain service capabilities and developing specialized platforms in niche areas, achieving significant results in new business sectors by the third quarter of 2025 [1] Group 1 - The company reported impressive performance in innovative drug services, import agency, health equipment, and CSO (Contract Sales Organization) businesses [1]